# Ellipsys Vascular Access System Post Market Surveillance (PS) Study

> **NCT04484220** · NA · COMPLETED · sponsor: **Medtronic Endovascular** · enrollment: 142 (actual)

## Conditions studied

- Renal Disease, End Stage
- Kidney Disease, End-Stage
- AV Fistula
- Fistulas Arteriovenous

## Interventions

- **DEVICE:** Ellipsys Vascular Access System

## Key facts

- **NCT ID:** NCT04484220
- **Lead sponsor:** Medtronic Endovascular
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-13
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04484220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04484220, "Ellipsys Vascular Access System Post Market Surveillance (PS) Study". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04484220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*